Latest Institute for OneWorld Health Stories
On April 11, the pharmaceutical company Sanofi will launch the large-scale production of a partially synthetic version of artemisinin, a chemical critical to making today's front-line antimalaria drug, based on Keasling's discovery.
Visceral Leishmaniasis program expands to support South Asian regional elimination efforts. San Francisco, CA (PRWEB) November 24, 2010 The Institute for OneWorld Health (iOWH), the US based non-profit pharmaceutical company with offices in San Francisco, USA and India that develops drugs for people with neglected infectious diseases in the developing world, today announced a new program in Nepal and Bangladesh to develop a therapy for Visceral Leishmaniasis (VL) available through a grant...
The Institute for OneWorld Health, the US-based non-profit pharmaceutical company that develops drugs for people with neglected infectious diseases in the developing world, today announced the appointment of Richard Chin, M.D., as its new Chief Executive Officer.